3.8 Review

Depressive symptoms in clinical and incipient Alzheimer's disease

Journal

NEURODEGENERATIVE DISEASE MANAGEMENT
Volume 3, Issue 2, Pages 147-155

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/NMT.13.10

Keywords

-

Funding

  1. National Institute on Aging [P50 AG 16570]
  2. Alzheimer's Disease Research Centers of California
  3. Sidell-Kagan Foundation
  4. National Institute on Ageing, American Federation for Aging Research [K08 AG 34628]
  5. John A Hartford Foundation
  6. Atlantic Philanthropies
  7. Starr Foundation

Ask authors/readers for more resources

The updated diagnostic criteria for Alzheimer's disease (AD) distinguish three stages: dementia, symptomatic predementia (i.e., mild cognitive impairment) and asymptomatic predementia. Although AD is primarily associated with cognitive deficits, comorbid depressive symptoms frequently occur at each stage. Depression in AD dementia is qualitatively different from depression in cognitively intact and/or younger populations, and may be less responsive to established interventions. In mild cognitive impairment, depressive symptoms are associated with higher rates of progression to dementia, and may identify a subset of individuals that are more responsive to acetylcholinesterase inhibitor treatment. Clinical and subsyndromal depressive symptoms in cognitively normal elderly individuals represent a risk factor and/or prodrome for dementia due to AD; however, sustained antidepressant therapy may be able to modulate this risk.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available